AMANDA NORMAN: Open Payments
NPI 1528786910 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 27 payments from 11 companies in 2025. Trend: 2023 $231 · 2024 $591 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $135 |
| Janssen Biotech, Inc. | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Ardelyx, Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $28 |
| Procept Biorobotics Corporation | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Celltrion USA Inc. | 1 | $18 |
Products named: GEMTESA, TREMFYA, ENTYVIO, IBSRELA, SKYRIZI, AQUABEAM ROBOTIC SYSTEM, DUPIXENT, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
